INVEX THERAPEUTICS LTD

Invex Therapeutics (IXC.AX) shares remain flat at AUD 0.10, with a 7.9 M market cap and a 52‑week range of AUD 0.09‑0.15; learn why investors track its neuro‑therapeutics focus.

Invex Therapeutics shares hold flat at AUD 0.10, amid low trading volume and upcoming capital‑reimbursement distributions.

Invex Therapeutics (IXC.AX) trades flat at AUD 0.10, targeting rare neurological and brain injury drugs; watch for clinical milestones that could boost its low‑cap stock.